Exclusive

Publication

Byline

Location

US Patent Issued to RACTIGEN THERAPEUTICS on April 21 for "Oligomeric nucleic acid molecule, and application thereof in an acute intermittent porphyria treatment" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,400, issued on April 21, was assigned to RACTIGEN THERAPEUTICS (Nantong City, China). "Oligomeric nucleic acid molecule, and application t... Read More


US Patent Issued to WATERSTONE PHARMACEUTICALS (WUHAN) on April 21 for "Polymers, compositions and methods for treating hyperuricemia" (Chinese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,401, issued on April 21, was assigned to WATERSTONE PHARMACEUTICALS (WUHAN) Co. LTD. (Wuhan, China). "Polymers, compositions and methods f... Read More


US Patent Issued to APR Applied Pharma Research on April 21 for "Therapeutic uses of oxidizing hypotonic acid solutions" (Swiss, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,402, issued on April 21, was assigned to APR Applied Pharma Research SA (Geneva). "Therapeutic uses of oxidizing hypotonic acid solutions"... Read More


US Patent Issued to WIAB WATER INNOVATION on April 21 for "Compositions and methods for treating transient biofilms" (Norwegian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,403, issued on April 21, was assigned to WIAB WATER INNOVATION AB (Malmo, Sweden). "Compositions and methods for treating transient biofil... Read More


US Patent Issued to Ionic Alliance Foundation on April 21 for "Synthetic cellular membrane chemical ionophore delivery system comprising hexa-aqua ligand compositions" (Michigan, Colorado Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,404, issued on April 21, was assigned to Ionic Alliance Foundation Inc (Indian Hills, Colo.). "Synthetic cellular membrane chemical ionoph... Read More


US Patent Issued to ORTHOGEN on April 21 for "Methods for the production of pharmaceutical agents" (German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,405, issued on April 21, was assigned to ORTHOGEN AG (Dusseldorf, Germany). "Methods for the production of pharmaceutical agents" was inve... Read More


US Patent Issued to The Trustees of Columbia University in the City of New York on April 21 for "Methods to induce terminal differentiation in stem cells by interfering with DNA replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof" (New York, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,407, issued on April 21, was assigned to The Trustees of Columbia University in the City of New York (New York). "Methods to induce termin... Read More


US Patent Issued on April 21 for "Method for the production of a product used for immune modulation and regeneration purposes in alopecia areata, androgenetic alopecia, scar, neurodegenerative inflammatory diseases" (Turkish Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,408, issued on April 21. "Method for the production of a product used for immune modulation and regeneration purposes in alopecia areata, ... Read More


US Patent Issued to University of South Florida on April 21 for "Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders" (Florida Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,409, issued on April 21, was assigned to University of South Florida (Tampa, Fla.). "Plasma derived from human umbilical cord blood for th... Read More


US Patent Issued to Minovia Therapeutics, Tel Hashomer Medical Research Infrastructure and Services on April 21 for "Mitochondria-enriched genetically engineered cells and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,410, issued on April 21, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel) and Tel Hashomer Medical Research Infrastructur... Read More